Largest opioid review finds limited benefits for acute pain

A comprehensive analysis of opioid medications for short-term pain has concluded that these drugs typically provide only modest and brief relief. The review, covering dozens of conditions, found that opioids often perform no better than placebos in many cases. Researchers from the University of Sydney led the effort and highlighted risks of side effects and dependence.

The study combined evidence from 59 systematic reviews involving more than 50 acute pain conditions in children and adults. It examined common opioids including codeine, morphine, oxycodone, and tramadol. The findings were published in the journal Drugs. Associate Professor Christina Abdel Shaheed noted that opioids did not deliver large or lasting relief compared with placebo for most conditions, with effects usually lasting only a few hours. Benefits appeared modest for certain situations such as dental surgery pain, stomach pain, and childbirth. No advantage over placebo was seen for kidney stone pain, some limb surgeries, or tonsil removal pain. The analysis also linked opioids to increased side effects like nausea and vomiting in several scenarios. Co-first author Dr. Stephanie Mathieson warned that dependence can develop quickly, sometimes within days of first use. The researchers advised doctors to prescribe the lowest effective dose for the shortest time and to inform patients of potential harms.

Verwandte Artikel

Das kolumbianische Ministerium für Gesundheit und Sozialschutz hat vor den Risiken eines übermäßigen Paracetamol-Konsums bei Minderjährigen gewarnt, der als „Paracetamol-Challenge“ bekannt ist. Diese durch soziale Medien beeinflusste Praxis führt zu Überdosierungen sowie zu schweren Leber- und Nierenschäden.

Von KI berichtet

Fentanyl-related overdose deaths in the US dropped by 34 percent from 2023 to 2024, falling from nearly 73,000 to under 48,000. This decline, observed across demographics and regions, appears linked to reduced purity in illegal fentanyl supplies. While marking progress in the opioid crisis, experts caution that other drug deaths are rising and the trend may not last.

An antioxidant called L-ergothioneine, found in certain mushrooms, reduced period pain in a small study of 40 women. Participants took a daily 120-milligram supplement over three menstrual cycles, reporting lower pain scores compared to a placebo group. The findings suggest it targets oxidative stress in uterine cells.

Von KI berichtet

Die Polizei von Delhi hat ein internationales Netzwerk zerschlagen, das verbotene verschreibungspflichtige Medikamente wie Zolpidem, Tramadol und Diazepam in die Vereinigten Staaten geschmuggelt hat. Fünf Personen – Abhishek Bhargava, Yasar Khan, Nitin, Neeraj Raghav und Amitesh Rai – wurden festgenommen. Die Beschlagnahmung eines Pakets in Moti Nagar deckte den Betrieb auf.

Diese Website verwendet Cookies

Wir verwenden Cookies für Analysen, um unsere Website zu verbessern. Lesen Sie unsere Datenschutzrichtlinie für weitere Informationen.
Ablehnen